Table 3. Patient characteristics: Acarbose vs nontreatment.
| Characteristic | Acarbose group | Nontreatment group | P |
|---|---|---|---|
| Patients, n | 89 | 84 | - |
| Age, years | 54.2±12.5 | 49.10±13.25 | 0.011 |
| Males, n (%) | 52 (58.4) | 48 (57.1) | 0.879 |
| Fasting plasma glucose, mmol/L | 9.88±4.48 | 10.48±5.82 | 0.460 |
| Postprandial plasma glucose, mmol/L | 17.51±7.34 | 18.70±5.78 | 0.301 |
| HbA1c, mmol/mol | 70.93±2.51 | 92.02±7.76 | 0.000 |
| HbA1c, % | 8.64±2.38 | 10.57±2.86 | 0.000 |
| Fructosamine, mmol/L | 384.27±114.89 | 440.65±142.74 | 0.027 |
| Chronic complications, n (%) | 44 (49.4) | 33 (39.3) | 0.221 |
| Acute complications, n (%) | 3 (3.4) | 11 (13.1) | 0.025 |
Data are presented as mean ± SD, number or percentage
P values were calculated using Student’s t test or χ2 test